
{
  "symbol": "IMAB",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": ["biotechnology sector", "small-cap company", "clinical stage developments"],
    "riskScore": 7,
    "reason": "I-Mab operates in the biotechnology sector, which is prone to speculation, and is a small-cap company with clinical stage developments, making it susceptible to retail-driven price movements."
  }
}
